NCT00293423 - GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 18, 2005

Primary Completion Date

January 12, 2013

Study Completion Date

January 12, 2013

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL

HSPPC-96

25 mcg

PROCEDURE

Standard Surgical Resection

Patients will undergo standard surgical resection of intracranial tumor

Trial Locations (3)

Columbia University, New York

University Hospitals Case Medical Center, Cleveland

University of California, San Francisco, San Francisco